CAMBRIDGE, MA—Rajavelu Esther, the Chief Financial Officer and Chief Business Officer of Spero Therapeutics , Inc. (NASDAQ:SPRO), recently executed a stock transaction involving the sale of ...

Esther Rajavelu has been appointed as Interim President and CEO, with Frank Thomas as Chairman of the Board. Concurrently, the company reported progress on its Phase 3 PIVOT-PO trial for Tebipenem ...

Esther Rajavelu has been appointed as Interim President and CEO, with Frank Thomas stepping in as Chairman of the Board. The company has also reported progress on its Phase 3 PIVOT-PO trial for ...

today announced that Esther Rajavelu, Spero’s Interim President and Chief Executive Officer, management will present and will be available for one-on-one meetings at the TD Cowen 45 th Annual ...

today announced that Esther Rajavelu, Spero’s Interim President and Chief Executive Officer, management will present and will be available for one-on-one meetings at the TD Cowen 45 th Annual ...